English | 简体中文 | 繁體中文 | 한국어
 English Press Releases
 Medicine BioTech
Junshi Biosciences Announces Financial Results for Six Months Ended June 30, 2020 and Provides Corporate Updates
Aug 31, 2020 08:20 HKT
Sino Biopharm Announces 2020 Interim Results
Aug 28, 2020 17:20 HKT
Novotech the Asia-Pacific CRO Leader - Awarded '2020 Frost & Sullivan Asia-Pacific CRO Company of the Year'
Aug 26, 2020 10:00 HKT
Sihuan Pharmaceutical Announces 2020 Interim Results
Aug 25, 2020 21:26 HKT
Ivermectin Triple Therapy Protocol for COVID-19 Released to Australian GPs for Infected Elderly and Frontline Workers
Aug 20, 2020 10:00 HKT
Bayer and Hua Medicine announce commercialization agreement and strategic partnership for investigational first-in-class novel diabetes treatment dorzagliatin in China
Aug 17, 2020 19:20 HKT
QBiotics Announces Clinical Collaboration with MSD Targeting Unresectable Melanoma
Aug 13, 2020 15:30 HKT
China Medical System Holdings Limited 2020 Interim Results Announcement
Aug 13, 2020 08:55 HKT
Impact Biomedical initiates Quantum, a new frontier in Pharmaceutical Development
Jul 31, 2020 15:00 HKT
Captiva Verde Announces Esmeralda Agreement with Mexican Health Care Workers Union for up to USD$142 Million per Year of Annual Product Sales
Jul 28, 2020 07:00 HKT
Aptorum Group Becomes the First Nasdaq Listed Biopharmaceutical Company Admitted to Trading on Euronext Paris Stock Exchange Under the Ticker Symbol APM
Jul 27, 2020 15:18 HKT
MP Biomedicals and A*STAR Co-Develop Rapid Antibody Test Kit for SARS-CoV-2
Jul 24, 2020 17:00 HKT
SinoMab entered into Strategic Collaboration with D2M
Jul 23, 2020 07:20 HKT
Genor Biopharma Announces Acceptance of New Drug Application for Geptanolimab and Appointment of Mr. CHEN Wende as Chief Operation Officer
Jul 21, 2020 17:37 HKT
Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization
Jul 20, 2020 08:05 HKT
Hao Tian Development Plans Joint Venture to Conduct Research and Develop Cell-based and Biological Therapies for the Treatment of Liver Diseases
Jul 14, 2020 17:27 HKT
Novotech Webinar: Why the Asia-Pacific is Attracting 10,000 Oncology Trials and How Biotechs Can Tap the Region
Jul 13, 2020 19:00 HKT
Avance Clinical Wins Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award
Jul 09, 2020 00:30 HKT
Hua Medicine Announces Positive 24-Week Topline Results of Phase III Metformin Combination Trial of Dorzagliatin
Jul 01, 2020 19:00 HKT
Captiva Verde Land Corp Announces Solargram Farms Corporation Receives Health Canada Standard Cultivation Cannabis License for Renauds Mills, New Brunswick
Jun 30, 2020 05:00 HKT
<< Previous  Next >>
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: